Investors

OvaScience is a global fertility company dedicated to improving treatment options for women around the world.

OVAS (Common Stock)
Price & Exchange
$6.93
NASDAQ
Change (%)
 Stock is Down 2.85 (29.14%)
Volume
4,745,123
05/26/16      4:00 p.m. ET

Minimum 20 minute delay
Refresh quote

Investor Overview

Recent News

More »
DateTitle 
05/26/16OvaScience Announces Pricing of Public Offering of Common Stock
WALTHAM, Mass.--(BUSINESS WIRE)--May 26, 2016-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it has priced its previously announced underwritten public offering of 7,150,000 shares of its common stock at a public offering price of $7.00 per share. Net proceeds to OvaScience from this offering are expected to be approximately $46.8 ... 
Printer Friendly Version
05/25/16OvaScience Announces Proposed Public Offering of Common Stock
WALTHAM, Mass.--(BUSINESS WIRE)--May 25, 2016-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it has commenced an underwritten public offering of shares of its common stock. OvaScience intends to grant the underwriters a 30-day option to purchase additional shares of the common stock to cover over-allotments, if any. All of the shares in ... 
Printer Friendly Version
05/05/16OvaScience Reports First Quarter 2016 Financial Results
— AUGMENT treatment gains traction in growing fertility market and Company expands access internationally — — New research supports AUGMENT and pipeline treatments— WALTHAM, Mass.--(BUSINESS WIRE)--May 5, 2016-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today reported its first quarter 2016 financial results and highlighted recen... 
Printer Friendly Version
04/28/16OvaScience to Host First Quarter 2016 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--Apr. 28, 2016-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.m. EDT on Thursday, May 5, 2016 to discuss first quarter 2016 financial results and provide a general corporate update. The live call can be accessed by dialing +1 888 424 8151 for U.S. call... 
Printer Friendly Version

Upcoming Events

More »
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources